News

AWS Case Study
Video: The benefits and efficiencies of building the uMotif platform on Amazon Web Services infrastructure
Read more

Making Pharma More Digital - Learnings From Startups
Video: Bruce Hellman shares his thoughts with McKinsey & Company on digitising pharma
Read more

On-Demand Webinar
Bruce Hellman joins AWS and FiercePharma to discuss powering virtual trials in the cloud
Read more

uMotif Raise £5 Million to Power Decentralised Clinical Trials and Get Therapies to Patients Faster
Press release: Series A investment round secured
Read more

uMotif Support NHS Study In The Fight Against Covid-19
Powering a BYOD NHS Covid-19 sinus wash study
Read more

On-Demand Webinar
Matt Bonam, of AstraZeneca, and Calum MacRae, of Brigham and Women's Hospital, join Bruce Hellman to discuss reimagining clinical trials
Read more

100 Healthtech Pioneers in 2020
uMotif recognised as one of BusinessCloud's top 100 Healthtech Pioneers
Read more

Patient-Centric eClinical Platform Powers Virtual Data Capture in European Hypoglycaemia Study
The Hypo-RESOLVE project
Read more

Informa Connect Industry Voices
Will Artificial Intelligence revolutionise clinical trials?
Read more

No Rain, No Pain: Study Links Foul Weather With Body Aches
Article: The Washington Post's coverage of the Cloudy With a Chance of Pain virtual study
Read more

The Spencer Group Podcast
Our CEO and Head of Global Business Development chat about how Covid-19 is accelerating the digitisation of research
Read more

On-Demand Webinar
LEO Innovation Lab and Jessica Morris, a wonderfully impatient patient, join Bruce Hellman to chat about how we can empower patients in virtual trials
Read more

Medical Futurist Interview
Article: Our CEO talks to Barts and the London MedTech Society about the impact of Covid-19
Read more
Will's Story
Video: Will Dixon, Professor of Digital Epidemiology at Manchester University, discusses the UK's largest virtual study: "Cloudy With a Chance of Pain"
Read more
Katie's Story
Video: Katie Druce, Patient and Public Engagement Lead at the Centre for Epidemiology Versus Arthritis, discusses two virtual research projects
Read more

Virtual Trials Take Centre Stage During Covid-19
Article: Our CEO talks to pharmaphorum on how virtual trials are evolving and why they are more important than ever in the midst of Covid-19
Read more
Riding The Technology Wave Into A New Decade
Blog: Our CEO looks ahead to the new year and decade
Read more

People-powered, Tech-enabled, Start-up Tackling Brain Cancer Launches in UK
Press release: OurBrainBank UK launch
Read more

uMotif Publish Validation Study of Parkinson’s Tapping Test with UCL and Queen Mary University
Digitising the finger tapping test
Read more

Cathy's Story
Video: Cathy wants to contribute to research and not keep data locked within her body
Read more

Bruce Hellman named in 2019 PharmaVOICE 100
Recognised in 100 of the Most Inspiring People
Read more

QUASAR Case Study
Powering largest remote study investigating sleep and quality of life for adults with rheumatoid arthritis
Read more

uMotif Recognised as One of the UK's 50 Most Disruptive Companies
Featured in the 2019 Disruption50 list
Read more

uMotif Feature in BusinessCloud's 101 HealthTech Innovators
Recognised as one of the top British companies in healthtech
Read more

Impatient Patients and a New Approach to Disease Treatment
ICT article advocating giving back control to patients in their own disease management
Read more

Life As A New Starter At uMotif
Our uWrite interview series continues with insight into our Head of Data Reporting's first weeks at the company
Read more

uMotif Announce New Technology Advisor - Dr Alison Vincent, Former Cisco Chief Technology Officer
Building an advisory board of world-leading experts to make patient-centric clinical research a reality
Read more
We Are Hiring!
Want to be part of a team building software that is speeding drug development as well as putting patients at the centre?
Read more

uMotif Welcome Rachel Lowrey as Head of Marketing
Expanding the team to support global growth
Read more

uMotif Sponsoring 2019 ACDM Annual Conference
We look forward to the discussions and busting BYOD myths
Read more

Focusing On Company Culture
Our uWrite employee interview series continues with insight into how we maintain our uMotif identity and culture as the company grows
Read more

uMotif recognised in the Global Digital Health 100 for second year running
uMotif highlighted again as one of the most innovative health technology companies by The Journal of mHealth
Read more

uMotif to attend SCOPE Summit 2019 in Orlando
uMotif team to join life science industry leaders for in-depth discussion and breakout sessions on the latest advances in all aspects of clinical trial management and operations
Read more

uMotif to attend DIA Europe 2019 Conference in Vienna
uMotif team to join life science industry leaders, payers, patients and regulators to drive collaborative answers in medicines development and access to healthcare
Read more
Me, We and RWE. The Importance of Designing for the Patient First.
Article: uMotif CEO Bruce Hellman, Helen Matthews, The Cure Parkinson’s Trust and Jessica Morris, OurBrainBank, talk to ACT
Read more

Partnerships in Clinical Trials 2018: My top three takeaways
uMotif CEO, Bruce Hellman, shares his highlights from PCT 2018
Read more

‘Real-World Evidence Mythbusting’ in Clinical Trials Innovation
Article: Our CEO, Bruce Hellman, busts the five most common myths holding back patient-reported adoption
Read more

Join our Webinar: Delivering Patient-Centric Late Phase Research Using the Latest BYOD ePRO
Register for our webinar, featuring Professor Will Dixon, Chair in Digital Epidemiology at University of Manchester, Willie Muehlhausen, eCOA Expert, and uMotif's CEO Bruce Hellman
Read more
Read industry expert Dr Calum MacRae’s latest article in Clinical Leader
Featuring uMotif: Leading cardiologist and leader of One Brave Idea, Dr Calum MacRae, discusses the importance of capturing real-world evidence to close the gap between the R&D process and healthcare delivery.
Read more

uMotif attending Partnerships in Clinical Trials Europe Conference in Barcelona
uMotif team to join pharma, biotech and CRO experts to discuss the importance of patient engagement and the impact of real world evidence on clinical research
Read more

uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board
uMotif building an advisory group of world-leading experts to make patient-centric clinical research a reality
Read more
Article: Human Centred Design - A Pathway to Patient Centricity
Check out our latest article exploring the importance of human centred design for true patient centricity in pharmaceutical research, authored by our CEO Bruce Hellman and IDEO Portfolio Director Betsy Fields Smith.
Read more
We're Hiring!
We're further strengthening our sales and marketing team - putting the patient at the centre of clinical research. Come and join us!
Read more

An Unforgettable First SCDM Experience in Seattle
uMotif CEO, Bruce Hellman, shares his highlights from SCDM 2018
Read more

uMotif attending SCDM 2018 Annual Conference in Seattle
uMotif team to join life science & data management colleagues to discuss the importance of patient-centric design in real world data capture
Read more

uMotif nominated for OBN award
We're a finalist in the 'Best implementation of digital technology for healthcare' category
Read more

Our employee interview series continues with a technology focus
Learn about how we manage our Infrastructure and ensure performance with Michal and Greg
Read more

uMotif secures £2.4 million funding - led by Albion Capital
We're delighted to secure this round of funding. It will enable us to bring on even more world class talent and remain at the forefront of patient-centric technology.
Read more

uMotif and OMRON Healthcare join forces to deliver patient-centred clinical research of the future
Creating a complete solution for cost-efficient, fast and high-quality clinical research by integrating high quality vitals, eCOA / ePRO and symptoms data
Read more

We're hiring!
We're growing across the company - building the team to put patients at the centre of clinical research. Come join us!
Read more

uMotif welcome Jonathan Stone as Vice President of Business Development (Americas and APAC)
uMotif investing in top business development talent to help the industry put the patient at the centre of clinical research.
Read more

Guardian Article: The app that could save lives by speeding up drug trials
uMotif profiled in major newspaper highlighting the importance of patient first trials and people owning their own data
Read more

Introducing our series of employee blogs and interviews with the uMotif team
uWrite Volume 1: Quality with Michael Burke, QMS specialist
Read more

Knect 365 article: Enabling Bring Your Own Device Clinical Data Collection
uMotif CEO Bruce Hellman explores how patient-centric data capture can revolutionise clinical trials
Read more
uMotif collaborating with IQVIA and Emis Health for NIHR We've Got Your Back study
Unique approach to use an integrated platform to help GPs recruit more patients in clinical research
Read more

OurBrainBank publishes first feedback from patients
The glioblastoma initiative, supported by uMotif, is receiving fantastic feedback from patients and their caregivers as well as insights into what they expect from their care
Read more

Steve Powell joins uMotif Board of Directors
uMotif adds the accomplished software leader behind some of the most successful patient engagement and clinical trial management platforms to our leadership team.
Read more
uMotif featured in the Promise of HealthTech report
Report names uMotif as one of the 27 most promising HealthTech companies
Read more

uMotif partnering with Novartis and IQVIA on NHS Cancer Vanguard project
We’re delighted to be providing our data capture platform to support this work
Read more
5 Reasons to Join a Trade Mission
Rob Nichols, VP of Customer Experience, fresh from such a trip to Vienna, gives his view
Read more
Read our article published in the latest Journal of mHealth
Driving Real-World Research Through Patient-Centric Engagement
Read more
Our team grows with over 10 new hires since the start of 2018
We're building the team to deliver next generation patient data capture platform for clinical research
Read more

uMotif powered non-profit tackling brain cancer is now live
OurBrainBank is created by, with and for patients with Glioblastoma - one of the most aggressive, complex and deadly forms of cancer.
Read more

uMotif nominated by Journal of mHealth in the 'Global Digital Health 100'
We're delighted to have been nominated as one of the world's leading digital health companies by the Journal of mHealth
Read more
Deployment in colorectal cancer at Christie Cancer Vanguard proven successful
A poster presentation at the BOPA conference in the UK shows successful deployment of uMotif at the Christie hospital
Read more

uMotif platform proven to engage patients in studies
A paper published in JMIR demonstrates that uMotif is the most effective platform to engage patients in data capture for research
Read more

Patients, like holidaymakers, should be at the centre of their journey
Hotwire featured an article on patient centricity by our CEO, Bruce Hellman
Read more

Self-tracking proven to improve cancer survival rates
A peer-review published study has shown that patients who self-track their health have significantly better cancer outcomes and survival rates
Read more

uMotif powering new patient-centric movement in brain cancer
A new patient-powered movement - Our Brain Bank - aims to move brain cancer from terminal to treatable, powered by patients using uMotif technology
Read more

Amazon Web Services case study on uMotif
Our cloud based data capture technology has been featured as a case study by Amazon Web Services, our hosting provider
Read more

uMotif wins 'Professional's Choice' category at AXA PPP HealthTech & You Awards
We picked up another award at the AXA PPP HealthTech & You Awards, scooping the 'Professional's Choice' category for engaging patients in large-scale research projects
Read more

New partnership with SQN for patient-centric data capture for clinical trials
Our new partnership will provide clinical trial sponsors with patient-centric technology for trials of all phases, including Real-World Evidence.
Read more

uMotif featured on BBC World Service 'World Hacks' programme
The BBC World Service's programme 'World Hacks' covered the growing interest in patients donating their health data for research, focusing on the uMotif platform
Read more

The dataset from 100 For Parkinson's exceeds 2.2 million data points
The final patients have completed their 100 Days of tracking for 100 For Parkinson's, so we now have the final dataset containing over 2.2 million datapoints. The latest analyses are ...
Read more

uMotif signs new partnership with AstraZeneca to enhance patient data capture
uMotif has signed a partnership agreement with AstraZeneca, a top-10 global pharmaceutical company
Read more

uMotif and QuintilesIMS in partnership with the NHS Cancer Vanguard and Merck launch a unique investigation into the experience of Colorectal Cancer Patients
uMotif in partnership with QuintilesIMS was chosen from dozens of responses to the ‘Pharma Challenge’, an invitation issued by the NHS Cancer Vanguard to the pharmaceutical and life sciences industry to help the NHS make better use of medicines and minimise waste.
Read more

Gold-standard RCT shows that uMotif effectively engages patients to track and manage their condition over time - resulting in significant clinical impact
A new study in Parkinson’s proves the value and clinical impact of patients using their own devices to capture and monitor symptoms and treatments.
Read more

Sam's Story
Video: Through using the uMotif app Sam gained a better understanding of her Parkinson's.
Read more

uMotif announce partnership with Global Kinetics
Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease.
Read more

Mick's Story
Video: Mick, a participant in a Parkinson's observational study, describes his experience using the uMotif app.
Read more
Cloudy with a Chance of Pain is Front Page News!
Our collaboration with the University of Manchester is featured on the FRONT PAGE of the Daily Express today - describing the preliminary findings that the weather may.....
Read more

100 For Parkinson’s enters its last two weeks of recruitment
Our ground-breaking study in partnership with The Cure Parkinson’s Trust, Parkinson’s UK and the European Parkinson’s Disease Association is entering the last two weeks of recruitment. There’s still time for people with Parkinson’s and healthy volunteers to join over 4000 others and track their health for 100 days using their own smartphone or tablet.
Read more

Digital Innovators Power List
umotif has been named as one of the South East's most visionary digital companies in the inaugural 'Digital Innovators Power List' launched today by international law firm Bird & Bird LLP and London-based news brand, City A.M.
Read more

uMotif and Oxford University Innovation collaborate on world’s largest health tracking study to improve the lives of those with Parkinson’s
One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition. A unique global health project – 100 for Parkinson’s - has engaged thousands of people across the world to track their health, using smartphone technology, to provide valuable new insights on the impact of Parkinson’s on their daily lives. With over 4,000 participants and millions of data points captured, the study is now the world’s largest of its type in Parkinson’s, capturing more high quality health data from more patients over a longer period of time.
Read more

It's World Parkinson's Congress and we've more data to share...
World Parkinson's Congress is ending today in Portland, so we've published some more data from 100 For Parkinson's on Mood, Sleep and Stress levels of those with and without Parkinson's...
Read more

Cloudy with a Chance of Pain study
Preliminary results, national media coverage and another 2,500 participants: It's been another couple of eventful weeks for the ground-breaking Cloudy with a Chance of Pain study
Read more

Partnership with Picker Institute, using patient experience to reduce readmissions
We're delighted to be working in partnership with the Picker Institute – the leading charity improving healthcare through measurement of experience.
Read more

Data from global 100 for Parkinson’s study
We launched our global 100 for Parkinson's study at the start of 2016, and have had an incredible response.
Read more

Guardian article: People powered health
uMotif CEO Bruce Hellman wrote an article in the Guardian on the future of technology in healthcare.
Read more

IDEO Startup In Residence
A year ago the uMotif team started working with the IDEO London team, as part of their incredible Startup In Residence Programme.
Read more